FRTX

Fresh Tracks Therapeutics, Inc. Common Stock

FRTX

Börsenwert 4,72 Mio. $

Nicht mehr börsennotiert

FRTX wurde am 18. Dezember 2023 von der Börse genommen.

Profil: Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.

Mitarbeiter: 13

Gesundheitswesen Arzneimittelhersteller – allgemein

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 0 %

Neutral 0 %

Negativ 0 %

Neutral

GlobeNewsWire

vor 2 Jahren

Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th

Common stock expected to begin trading on over-the-counter market following suspension Common stock expected to begin trading on over-the-counter market following suspension

Neutral

GlobeNewsWire

vor 2 Jahren

Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders

Meeting adjourned to December 27, 2023 at 10 a.m. MT

Neutral

GlobeNewsWire

vor 2 Jahren

Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders

Meeting adjourned to December 15, 2023 at 10 a.m. MT

Neutral

GlobeNewsWire

vor 2 Jahren

Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders

Meeting adjourned to November 30, 2023 at 10 a.m. MT Fresh Tracks encourages all stockholders of record on October 17, 2023 who have not yet voted to do so by 11:59 p.m.

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt

Fresh Tracks Therapeutics, Inc. Common Stock FRTX Börsenwert 4,72 Mio. $

Nachrichten

Fresh Tracks Therapeutics, Inc. Common Stock

FRTX

Börsenwert 4,72 Mio. $